# Micro Therapeutics Dba Ev3 Neurovascular

- Location (FDA's records): Irvine, CA
- FDA decisions: 4 (2010–2015): 4 510(k) clearances
- Names in FDA's records: Micro Therapeutics Dba Ev3 Neurovascular (3); Micro Therapeutics Inc Dba Ev3 Neurovascular (1)
- Product codes: NRY (2), DQY (1), MJN (1)
- Predicates its devices cite: 19 (1 its own); citations of its devices by later devices: 10 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Concentric Medical, Inc.: 7 (https://510kreport.com/company/concentric-medical)
- Micro Therapeutics, Inc.: 6 (https://510kreport.com/company/micro-therapeutics)
- Ev3, Inc.: 2 (https://510kreport.com/company/ev3)
- Ev3 Neurovascular: 2 (https://510kreport.com/company/ev3-neurovascular)
- Reverse Medical Corporation: 1 (https://510kreport.com/company/reverse-medical)

## Firms that cite its devices most
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular: 5 (https://510kreport.com/company/micro-therapeutics-d-b-a-ev3-neurovascular)
- Neuravi, Ltd.: 1 (https://510kreport.com/company/neuravi)
- Imperative Care, Inc.: 1 (https://510kreport.com/company/imperative-care)
- Stryker Neurovascular: 1 (https://510kreport.com/company/stryker-neurovascular)
- Kai Medtech, LLC: 1 (https://510kreport.com/company/kai-medtech)

## Its most-cited devices
- K113455: Solitaire FR Revascularization Device (2012), cited by 5
- K150107: Arc Intracranial Support Catheter, Arc Mini Intracranial Support Catheter (2015), cited by 2
- K123378: Solitaire 2 Revascularization Device (2012), cited by 2
- K101570: Hyperglide and Hyperform Occlusion Balloon Systems (2010), cited by 1

## Recent decisions
- K150107: Arc Intracranial Support Catheter, Arc Mini Intracranial Support Catheter (Jul 29, 2015)
- K123378: Solitaire 2 Revascularization Device (Nov 30, 2012)
- K113455: Solitaire FR Revascularization Device (Mar 2, 2012)
- K101570: Hyperglide and Hyperform Occlusion Balloon Systems (Jul 13, 2010)

Source page: https://510kreport.com/company/micro-therapeutics-dba-ev3-neurovascular